How Axumin can help
If you have recurrent prostate cancer, your doctor needs to get more accurate information about the location of your disease.
An Axumin scan may help. Hear directly from an Axumin patient >
“An Axumin PET/CT scan may help my doctor and me make important treatment decisions.”
After the injection, Axumin travels into your cancer cells—including prostate cancer cells—and lights up in the PET/CT scan. An imaging physician will review your scan to find out where the recurrent prostate cancer is located. It’s important to note that Axumin may not detect all recurrent prostate cancer, especially at very low PSA levels.
Inject
3 to 5 minutes
before the scan
Scan
takes around
20 to 30 minutes
Review
and discuss
at your next visit
As with all diagnostic imaging tests, it is possible that a physician can interpret your Axumin PET/CT scan results incorrectly. This means that a negative Axumin PET/CT scan does not rule out a prostate cancer recurrence. Similarly, a positive Axumin PET/CT scan does not confirm a prostate cancer recurrence.
Axumin® (fluciclovine F 18) injection is a diagnostic imaging agent (sometimes called a radiotracer). Axumin is used along with a positron emission tomography (PET) imaging scan for men who have had prior treatment for prostate cancer and now have prostate specific antigen (PSA) levels that are elevated.
Most commonly reported adverse reactions are:
Tell your doctor if you have any side effect that bothers you or does not go away.
These are not all the possible side effects of Axumin. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
You are now leaving Axumin.com. Do you wish to proceed?